• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store

The Promise of State-of-the-Art Sequencing Technologies for Cancer Screening

by Damon Anderson, PhD | Dec 22, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

Circulating tumor DNA sequencing technologies are tackling the challenges of early cancer detection.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here

Improving the Chances of Early Breast Cancer Detection in High-Risk Patients

by Glenn S. Demby | Dec 21, 2022 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Emerging Tests-dtet

A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Blood-Based Tests Can Detect Early-Stage Lung Cancer

Blood-Based Tests Can Detect Early-Stage Lung Cancer

by Glenn S. Demby | Jul 7, 2022 | News, Open Content

Team creates a mass spectrometry-based blood lipid test that, when combined with AI, identifies early signs of the disease.

Liquid Biopsy Can Rule Out Post-Surgery Chemotherapy for Colon Cancer

Liquid Biopsy Can Rule Out Post-Surgery Chemotherapy for Colon Cancer

by Glenn S. Demby | Jun 28, 2022 | News, Open Content

A post-surgery liquid biopsy test capable of detecting ctDNA could eliminate the need for chemotherapy for some stage II cancer patients.

A Faster, Simpler Liquid Biopsy Assay for Breast Cancer

A Faster, Simpler Liquid Biopsy Assay for Breast Cancer

by Rachel Muenz | Jun 27, 2022 | News, Open Content

Research team’s prototype test is easier to use than current methods and can detect cancer markers within 4.5 hours.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com